ScripsAmerica, Inc. engages in the distribution of generic and over-the-counter (OTC) drugs to hospitals, nursing homes, government agencies, and retail. The company is headquartered in Clifton, New Jersey. The company went IPO on 2012-05-30. The firm's subsidiaries include Main Avenue Pharmacy Inc. (Main Avenue), DispenseDoc Inc. (DispenseDoc) and Pharmacy Administration, Inc. (Pharmacy Administration). The company also holds interests in P.I.M.D. International LLC (PIMD). Its operations consist of the sale and compounding of non-sterile topical and transdermal pain creams through Main Avenue; wholesale sales to independent pharmacies and other medical providers through PIMD; pharmacy dispensing services for individual doctors through DispenseDoc, and billing and administrative services through Pharmacy Administration. Main Avenue's prescription pain creams incorporate approximately eight active pharmaceutical ingredients for application on the skin and in localized areas. As of December 31, 2014, PIMD held licenses in over 20 states to receive, store and ship Schedule 3 through Schedule 5 formulary pharmaceuticals.
Follow-Up Questions
What is ScripsAmerica Inc (SCRCQ)'s P/E Ratio?
The P/E ratio of ScripsAmerica Inc is 0
Who is the CEO of ScripsAmerica Inc?
Mr. Brian Ettinger is the Chairman of the Board of ScripsAmerica Inc, joining the firm since 2011.
What is the price performance of SCRCQ stock?
The current price of SCRCQ is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for ScripsAmerica Inc?
ScripsAmerica Inc belongs to Retail industry and the sector is Consumer Staples
